One of the hallmarks of AD pathology is the accumulation of Aβ species, generated by alternative cleavage of the amyloid precursor protein (APP), in diffuse and condensed plaques in the brain (Hardy & Selkoe, 2002; Eisenberg & Jucker, 2012). This evidence concerns the gene APP and Alzheimer disease.